BCV
AXSM icon

Banque Cantonale Vaudoise’s Axsome Therapeutics AXSM Stock Holding History

Banque Cantonale Vaudoise’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
+1,269
New +$275K 0.04% 140
2020
Q2 		– Sell
-1,466
Closed -$86K – 898
2020
Q1 		$86K Buy
+1,466
New +$119K 0.01% 784

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Banque Cantonale Vaudoise's AXSM Position: Q2 2026 in Review

Banque Cantonale Vaudoise opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 1,269 shares worth $311K. The stake represents 0.04% of the portfolio and ranks #140 among its holdings. This is a return to the name: Banque Cantonale Vaudoise previously reported a position in AXSM as recently as Q1 2020.

Banque Cantonale Vaudoise first reported a position in AXSM in Q1 2020 and has held it in 2 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Banque Cantonale Vaudoise held 1,269 shares of Axsome Therapeutics worth $311K as of Q2 2026.
  • Axsome Therapeutics was a new Banque Cantonale Vaudoise position in Q2 2026.
  • Axsome Therapeutics made up 0.04% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #140 holding.
  • Banque Cantonale Vaudoise first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 2 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.